17 August 2020 - Australia’s biggest health company, CSL, has confirmed it is in talks with British pharmaceutical giant AstraZeneca about producing its vaccine in Melbourne as part of its efforts to ensure there are doses available to inoculate Australians when a drug hits the market.

The discussions with AstraZeneca come as CSL is completing clinical trials with the University of Queensland on its molecular clamp vaccine candidate.

AstraZeneca chief executive Pascal Soriot joined CSL’s board as an independent non-executive director earlier this month.

Read The Australian article